These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 7038499

  • 1. More on sulfinpyrazone after myocardial infarction.
    Hood WB.
    N Engl J Med; 1982 Apr 22; 306(16):988-9. PubMed ID: 7038499
    [No Abstract] [Full Text] [Related]

  • 2. Sulfinpyrazone after myocardial infarction.
    N Engl J Med; 1978 Jun 01; 298(22):1257-9. PubMed ID: 349383
    [No Abstract] [Full Text] [Related]

  • 3. Sulfinpyrazone after myocardial infarction: no decision yet.
    Relman AS.
    N Engl J Med; 1980 Dec 18; 303(25):1476-7. PubMed ID: 7432408
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The anturane reinfarction trial.
    Shepard DS, Zeckhauser RJ.
    N Engl J Med; 1980 Jul 03; 303(1):49. PubMed ID: 6990265
    [No Abstract] [Full Text] [Related]

  • 6. The anturane reinfarction trial.
    Schiff AA.
    N Engl J Med; 1980 Jul 03; 303(1):48. PubMed ID: 6990263
    [No Abstract] [Full Text] [Related]

  • 7. Sulphinpyrazone (Anturan) after myocardial infarction.
    Nicholson MR, Whitlock RM.
    N Z Med J; 1979 Sep 26; 90(644):263. PubMed ID: 390442
    [No Abstract] [Full Text] [Related]

  • 8. The anturane reinfarction trial.
    Rothlin M.
    N Engl J Med; 1980 Jul 03; 303(1):48. PubMed ID: 6103510
    [No Abstract] [Full Text] [Related]

  • 9. Myocardial re-infarction and sulphinpyrazone.
    N Z Med J; 1978 Aug 09; 88(617):106. PubMed ID: 362256
    [No Abstract] [Full Text] [Related]

  • 10. The FDA's critique of the anturane reinfarction trial.
    Temple R, Pledger GW.
    N Engl J Med; 1980 Dec 18; 303(25):1488-92. PubMed ID: 7432418
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Sulfinpyrazone in the prevention of sudden cardiac death after myocardial infarct].
    Foz M.
    Med Clin (Barc); 1980 Jun 10; 75(1):32-4. PubMed ID: 7392709
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Sulfinpyrazone in the prevention of sudden death after myocardial infarction.
    Anturane Reinfarction Trial Research Group.
    N Engl J Med; 1980 Jan 31; 302(5):250-6. PubMed ID: 6985706
    [Abstract] [Full Text] [Related]

  • 16. The Anturane Reinfarction Trial: reevaluation of outcome.
    N Engl J Med; 1982 Apr 22; 306(16):1005-8. PubMed ID: 7038496
    [No Abstract] [Full Text] [Related]

  • 17. Sulphinpyrazone in the prevention of cardiac death after myocardial infarction.
    S Afr Med J; 1980 Mar 01; 57(9):301-2. PubMed ID: 6986664
    [No Abstract] [Full Text] [Related]

  • 18. [Sulfinpyrazone (Anturan) after myocardial infarction].
    Faergeman O.
    Ugeskr Laeger; 1980 Sep 22; 142(39):2571-2. PubMed ID: 7445168
    [No Abstract] [Full Text] [Related]

  • 19. [Sulfinpyrazone in the prevention of sudden death after myocardial infarction (author's transl)].
    Sherry S.
    MMW Munch Med Wochenschr; 1980 Apr 04; 122(14):517-24. PubMed ID: 6769032
    [Abstract] [Full Text] [Related]

  • 20. The Anturane reinfarction trial.
    Sherry S.
    Thromb Haemost; 1979 Feb 28; 41(1):197-201. PubMed ID: 483231
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.